Literature DB >> 4611457

Prenylamine in treatment of angina.

H Tucker, P Carson, N Bass, J Massey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4611457      PMCID: PMC1020050          DOI: 10.1136/hrt.36.10.1001

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  7 in total

1.  Investigation of a possible beta-blocking action of prenylamine in man.

Authors:  R L Hodge
Journal:  Aust J Exp Biol Med Sci       Date:  1969-10

2.  Effect of prenylamine in angina pectoris.

Authors:  J B Stoker
Journal:  Br J Clin Pract       Date:  1968-09

3.  A 2-year study of the efficacy and tolerability of prenylamine in the treatment of angina pectoris.

Authors:  N Cardoe
Journal:  Postgrad Med J       Date:  1970-12       Impact factor: 2.401

4.  A double-blind, double cross-over trial of prenylamine in angina pectoris.

Authors:  R Winsor; K Bleifer; S Cole; I R Goldman; H Karpman; R Oblath; S Stone
Journal:  Am Heart J       Date:  1971-07       Impact factor: 4.749

Review 5.  Drugs in the management of angina pectoris.

Authors:  M B Matthews; W P Turck
Journal:  Practitioner       Date:  1969-02

6.  Differential amine depletion from cardiac adrenergic nerves by segontin.

Authors:  K C Nielsen; C Owman
Journal:  Experientia       Date:  1967-03-15

7.  The effect of prenylamine (segontin) on the amine levels of brain, heart and adrenal medulla in rats.

Authors:  H O Obianwu
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1965
  7 in total
  4 in total

1.  The effect of prenylamine on the QT interval of the resting electrocardiogram in patients with angina pectoris.

Authors:  D Oakley; K Jennings; R Puritz; D Krikler; D Chamberlain
Journal:  Postgrad Med J       Date:  1980-11       Impact factor: 2.401

2.  A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.

Authors:  N S Khurmi; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing.

Authors:  E Grenadier; S Keidar; G Alpan; A Marmor; A Palant
Journal:  Br Heart J       Date:  1980-09

Review 4.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.